LifeTech Scientific Corporation
LFTSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $677 | $651 | $653 | $628 |
| % Growth | 4% | -0.3% | 4% | – |
| Cost of Goods Sold | $179 | $185 | $137 | $137 |
| Gross Profit | $498 | $466 | $515 | $491 |
| % Margin | 73.6% | 71.6% | 78.9% | 78.2% |
| R&D Expenses | $114 | $163 | $140 | $187 |
| G&A Expenses | $118 | $92 | $73 | $90 |
| SG&A Expenses | $369 | $282 | $223 | $236 |
| Sales & Mktg Exp. | $251 | $190 | $150 | $146 |
| Other Operating Expenses | -$50 | $37 | -$49 | -$61 |
| Operating Expenses | $433 | $482 | $313 | $363 |
| Operating Income | $64 | -$16 | $202 | $128 |
| % Margin | 9.5% | -2.4% | 30.9% | 20.4% |
| Other Income/Exp. Net | $15 | $6 | $7 | -$209 |
| Pre-Tax Income | $80 | -$10 | $209 | -$81 |
| Tax Expense | $38 | $8 | $23 | $24 |
| Net Income | $55 | $17 | $206 | $43 |
| % Margin | 8.1% | 2.6% | 31.5% | 6.9% |
| EPS | 0.013 | 0.004 | 0.046 | 0.01 |
| % Growth | 225.6% | -91.5% | 379.2% | – |
| EPS Diluted | 0.013 | 0.004 | 0.046 | 0.01 |
| Weighted Avg Shares Out | 4,344 | 4,379 | 4,469 | 4,530 |
| Weighted Avg Shares Out Dil | 4,351 | 4,394 | 4,452 | 4,391 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $19 | $0 | $9 |
| Interest Expense | $0 | $2 | $0 | -$0 |
| Depreciation & Amortization | $40 | $51 | $37 | $31 |
| EBITDA | $71 | $80 | $208 | $122 |
| % Margin | 10.5% | 12.4% | 31.9% | 19.4% |